Literature DB >> 28633786

Metastatic Pulmonary Adenocarcinoma of the Talus: A Case Report.

Kaifeng Gan1, Yandong Shen2.   

Abstract

Tumors rarely metastasize to the foot bones; however, a misdiagnosis can lead to a poor outcome. These metastatic tumors can cause foot pain and other symptoms in patients who are asymptomatic for the primary tumor. To accurately diagnose acrometastases, the attending physician must have a high index of suspicion and conduct a thorough examination and appropriate diagnostic testing. We present a rare case of metastatic pulmonary adenocarcinoma of the talus, which was initially misdiagnosed as a benign bone cyst. After pulmonary adenocarcinoma was diagnosed, the patient received multidrug treatment for the primary and metastatic lesions and was still responding well at the 12-month follow-up visit.
Copyright © 2017 American College of Foot and Ankle Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  acrometastasis; ankle; benign bone cyst; foot; lung cancer; metastasis; tumor

Mesh:

Year:  2017        PMID: 28633786     DOI: 10.1053/j.jfas.2017.02.002

Source DB:  PubMed          Journal:  J Foot Ankle Surg        ISSN: 1067-2516            Impact factor:   1.286


  3 in total

1.  Percutaneous Osteoplasty for the Management of a Talar Metastasis: A Case Report.

Authors:  Mengmeng Chen; Hai Tang; Fei Feng
Journal:  J Pain Res       Date:  2021-06-01       Impact factor: 3.133

2.  A very rare presentation of lung cancer: Metastases to the distal phalanx of index-case report.

Authors:  Vlad-Adrian Afrăsânie; Anca Maria Adavidoaiei; Iuliana Hunea Zamisnicu; Ionut Gabriel Funingănă; Mihai Vasile Marinca; Bogdan Gafton; Dana Elena Clement; Marius-Ionut Păduraru; Irina Demşa; Lucian Miron; Teodora Alexa-Stratulat
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

Review 3.  Metatarsal metastasis from clear cell renal cell carcinoma: a case report and literature review.

Authors:  Hongzeng Wu; Ruoqi Han; Qianqian Zhang; Yi Zhao; Helin Feng
Journal:  BMC Urol       Date:  2020-02-24       Impact factor: 2.264

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.